Stage III Cutaneous Melanoma AJCC v7

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00041Aldesleukin1Recruiting1
DB00493Cefotaxime1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB08912Dabrafenib1Active Not Recruiting2
DB01073Fludarabine1Recruiting1
DB06186Ipilimumab1Active Not Recruiting1
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB09035Nivolumab1Recruiting1
DB06306Onalespib1Active Not Recruiting1
DB00740Riluzole1Active Not Recruiting1
DB06176Romidepsin1Active Not Recruiting1
DB00398Sorafenib1Active Not Recruiting1
DB08911Trametinib1Active Not Recruiting2
DB08912Dabrafenib1 / 2Recruiting1
DB05996Glembatumumab vedotin1 / 2Withdrawn1
DB06186Ipilimumab1 / 2Recruiting1
DB06186Ipilimumab1 / 2Withdrawn1
DB12340Navitoclax1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB09035Nivolumab1 / 2Withdrawn1
DB09037Pembrolizumab1 / 2Recruiting1
DB08911Trametinib1 / 2Recruiting1
DB00945Acetylsalicylic acid2Recruiting1
DB08885Aflibercept2Completed1
DB00041Aldesleukin2Completed1
DB11791Capmatinib2Recruiting1
DB09063Ceritinib2Recruiting1
DB08912Dabrafenib2Active Not Recruiting1
DB08912Dabrafenib2Recruiting1
DB11986Entrectinib2Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB06186Ipilimumab2Recruiting2
DB09035Nivolumab2Recruiting2
DB09037Pembrolizumab2Recruiting2
DB08896Regorafenib2Recruiting1
DB00020Sargramostim2Active Not Recruiting1
DB13896Talimogene laherparepvec2Recruiting1
DB08911Trametinib2Active Not Recruiting1
DB08911Trametinib2Recruiting1
DB06186Ipilimumab2 / 3Suspended1
DB09035Nivolumab2 / 3Suspended1
DB00020Sargramostim2 / 3Suspended1
DB08912Dabrafenib3Recruiting1
DB00105Interferon alfa-2b3Active Not Recruiting1
DB06186Ipilimumab3Active Not Recruiting1
DB06186Ipilimumab3Recruiting1
DB09035Nivolumab3Recruiting1
DB09037Pembrolizumab3Active Not Recruiting1
DB08911Trametinib3Recruiting1